|
Author
|
Year
|
Country
|
N
|
nc
|
np
|
RCT
|
N (men)
|
BMI
|
Preparation
|
Exercise
|
Age (mean)
|
Dose
|
Outcome
|
|---|
|
Drobnic F
|
2014
|
Spain
|
19
|
9
|
10
|
Parallel
|
19
|
24.6
|
Meriva
|
Downhill running
|
35.4
|
1 g bid
|
VAS CK
|
|
Nicol LM
|
2015
|
New Zealand
|
17
|
17
|
17
|
Crossover
|
17
|
-
|
Capsules
|
Leg press
|
33.8
|
2.5 gm bid
|
VAS CK TNF IL
|
|
Tanabe Y
|
2015
|
japan
|
14
|
14
|
14
|
Crossover
|
14
|
22
|
Theracurmin
|
Elbow flexor
|
23.5
|
150 mg bid
|
VAS CK TNF IL ROM
|
|
McFarlin BK
|
2016
|
USA
|
28
|
14
|
14
|
Parallel
|
10
|
22.5
|
Longvida
|
Leg press
|
19.5
|
200, 400, 1000 mg
|
VAS CK TNF IL
|
|
Naknhostin-Roohi B
|
2016
|
Iran
|
10
|
10
|
10
|
Crossover
|
10
|
25.6
|
Theracurmin
|
squat exercises
|
25
|
150 mg
|
VAS CK
|
|
Basham SA
|
2019
|
USA
|
20
|
20
|
20
|
Crossover
|
20
|
26.7
|
CurcuFresh
|
Leg press
|
21.7
|
1.5 g
|
VAS CK TNF
|
|
Amalraj A
|
2020
|
India
|
30
|
15
|
15
|
Parallel
|
12
|
23.3
|
AB
|
Downhill running
|
36
|
500 mg
|
VAS CK
|
|
Jäger R
|
2019
|
USA
|
63
|
42
|
21
|
Parallel
|
31
|
25.6
|
CurcuWIN
|
Downhill running
|
21
|
50, 200 mg
|
VAS
|
|
Tanabe Y
|
2019
|
japan
|
24
|
16
|
8
|
Parallel
|
24
|
22.1
|
Theracurmin
|
Elbow flexor
|
28.3
|
180 mg 7 day
|
VAS CK ROM
|
|
Tanabe Y scan
|
2019
|
japan
|
20
|
10
|
10
|
Parallel
|
20
|
23.5
|
Theracurmin
|
Elbow flexors
|
28.75
|
180 mg
|
VAS CK TNF IL ROM
|
|
Cardaci TD
|
2020
|
USA
|
23
|
11
|
12
|
Parallel
|
11
|
24.6
|
UPS
|
Treadmill
|
21.13
|
2 g
|
VAS
|
|
Mallard AR
|
2020
|
New Zealand
|
27
|
13
|
14
|
Parallel
|
27
|
25.6
|
LipiSperse
|
LL resistance
|
26
|
427 mg
|
VAS CK TNF IL
|
|
Hillman AR
|
2021
|
USA
|
22
|
11
|
11
|
Parallel
|
17
|
25.4
|
Capsules
|
Plyometric
|
21.5
|
475 mg
|
VAS CK
|
- UPS ubiquitin proteasome system, LL lower limb, AB aurea biolabs
